<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the presence of <z:chebi fb="1" ids="29101">Na+</z:chebi>-dependent, active, sugar transport in Barrett's epithelia as an intestinal biomarker, based on the well-documented, morphological intestinal phenotype of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We examined uptake of the nonmeta-bolizable <z:chebi fb="105" ids="17234">glucose</z:chebi> analogue, alpha-<z:chebi fb="0" ids="37657">methyl-D-glucoside</z:chebi> (AMG), a substrate for the entire <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="105" ids="17234">glucose</z:chebi> cotransporter (SGLT) family of transport proteins </plain></SENT>
<SENT sid="2" pm="."><plain>During upper endoscopy, patients with BE or with uncomplicated <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) allowed for duodenal, gastric fundic, and esophageal mucosal biopsies to be taken </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsies were incubated in bicarbonate-buffered saline (KRB) containing 0.1 mmol/L <z:chebi fb="32" ids="36927">14C</z:chebi>-AMG for 60 min at 20 centigrade </plain></SENT>
<SENT sid="4" pm="."><plain>Characterized by abundant SGLT, duodenum served as a positive control while gastric fundus and <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, known to lack SGLT, served as negative controls </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Duodenal biopsies accumulated 249.84+/-35.49 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) picomoles AMG/microg DNA (n=12), gastric fundus biopsies 36.20+/-6.62 (n=12), <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus 12.10+/-0.59 (n=3) and Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> 29.79+/-5.77 (n=8) </plain></SENT>
<SENT sid="6" pm="."><plain>There was a statistical difference (P&lt;0.01) between biopsies from duodenum and each other biopsy site but there was no statistically significant difference between <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus and BE biopsies </plain></SENT>
<SENT sid="7" pm="."><plain>0.5 mmol/L <z:chebi fb="0" ids="8113">phlorizin</z:chebi> (PZ) inhibited AMG uptake into duodenal mucosa by over 89%, but had no significant effect on AMG uptake into gastric fundus, <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus, or Barrett's tissue </plain></SENT>
<SENT sid="8" pm="."><plain>In the absence of <z:chebi fb="1" ids="29101">Na+</z:chebi> (<z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="1" ids="29101">Na+</z:chebi> salts replaced by Li+ salts), AMG uptake in duodenum was decreased by over 90%, while uptake into gastric, esophageal or Barrett's tissue was statistically unaffected </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Despite the intestinal enterocyte phenotype of BE, <z:chebi fb="1" ids="29101">Na+</z:chebi>-dependent, sugar transport activity is not present in these cells </plain></SENT>
</text></document>